Postgraduate Teaching (PGT) 

October 14 – 15, 2023

The PGT Programme occurs during UEG Week with two days of excellent Continuing Medical Education 

Keep on track with your training

PGT is a dynamic, live, two-day, in-person educational experience! It focuses on the relevance for the clinical day-to-day business and provides profound updates on the latest developments in GI and hepatology topics.

Join lively experiences containing interactive audience voting, tricky clinical cases, controversial debates, real-time faculty engagement, and exciting cases. 

The 3-year curriculum has returned and will follow the curriculum for year 3 in 2023.

An application will be made shortly to the EACCME® for CME accreditation of this event. 

PGT programme: October 14 (09:00 CEST) – October 15 (11:30 CEST)

PGT 2023

Target group
  • Field of practice: Gastroenterologists in training and in practice; GI physicians and general practitioners with an interest in GI & hepatology topics
  • Career level: Fellows in training, established doctors (except top experts, specialists, researchers)
  • No age restriction
PGT recordings

Recordings of past PGT presentations are available online in the UEG Library.

Access recent PGT recordings collection

Learning Objectives

3-year Curriculum

The PGT follows a 3-year curriculum, which is based on recommendations of the ESBGH Curriculum – The Blue Book. Delegates can start the curriculum at any year of the cycle and will receive a certificate once they have completed all three years. 2023 is year 3 of the curriculum!

Search the PGT Curriculum and its learning objectives per topic:
Colorectal, Endoscopy and imaging, IBD, Liver, Oesophagus, Nutrition, Pancreas and biliary tract, Small bowelStomach and Therapy update

  • Year 3: Colorectal (2023 / 2026)
  • Year 1: Colorectal (2021 / 2024)
  • Year 2: Colorectal (2022 / 2025)
Year 3: Colorectal (2023 / 2026)

Advanced colorectal cancer
•    How to approach metastatic CRC: Systemic therapy vs surgery 
•    Role of chemotherapy in metastatic colon and rectal cancer with emphasis on precision therapy 
•    Other aspects of palliation: biliary and colonic stenting (maybe debate) 

•    Diagnostic work-up of constipated patients depending on age and symptoms
•    Role of diet, physical activity, fluid intake etc.
•    Medical therapy
•    Biofeedback and other behavioural treatment alternatives
•    Indications for surgery, including sacral nerve stimulation

Diverticular disease
•    Pathogenesis of diverticular disease
•    Management of symptomatic disease
•    Management of acute diverticulitis
•    Role of imaging and endoscopy in diverticular disease management

•    Identification and management of common proctological problems, including haemorrhoids, fissures and pruritus ani
•    Investigation and management of anal fistula, including imaging and surgical management
•    Defaecatory and continence disorders and the pelvic floor

Year 1: Colorectal (2021 / 2024)

Faecal incontinence
•    Pathophysiology and differential diagnosis of faecal incontinence
•    Manometric classification of anorectal disorders
•    Current tests of anorectal motor and sensory function
•    Therapeutic management: Conservative, pharmacological, behavioural and surgical modalities

Infectious colitis
•    Evaluation, differential diagnosis and management of patients with acute diarrhoea
•    Clostridium difficile: First-line management and recurrent infections
•    Faecal transplantation: Indications and modalities

Management of abdominal emergencies
•    Overview of potential causes of the acute abdomen (non-surgical and surgical)
•    Clinical assessment, laboratory and imaging diagnostic tools
•    Initial therapeutic management of the acute abdomen
•    Novel areas of development and innovations

Management of colorectal polyps and early colorectal cancer 
•    Screening strategies according to risk stratification
•    Endoscopic detection, characterisation and reporting
•    Therapeutic management: From endoscopy to surgery

Year 2: Colorectal (2022 / 2025)

Chronic diarrhoea
•    Differential diagnosis of chronic diarrhoea, including microscopic colitis, malabsorption, bile acid diarrhoea, etc.
•    Different tools for the diagnostic work-up
•    Therapeutic management

Colorectal cancer: Staging, surgery and adjuvant therapies
•    Staging and the multidisciplinary team meeting (including guidelines)
•    Evidence-based surgical management with curative intent, inclunding ERAS, etc.
•    Surgery for colorectal liver metastases
•    Neoadjuvant and adjuvant therapies for colon and rectal cancer

Colorectal polyps
•    Classification and endoscopic characterisation
•    Management and surveillance for sporadic polyps
•    Familial syndromes: Presentation and management

•    Diagnosis of IBS: What is the optimal work-up?
•    Medical treatment options, including pharmacological management, for IBS according to the clinical presentation (IBS-C, IBS-D)
•    Dietary management of IBS
•    Psychosocial management
•    IBS overlap syndromes

Lower GI bleeding
•    Clinical assessment, investigation and therapy for acute lower GI bleeding
•    Diagnosis and management of small and large bowel ischaemia

  • Year 3: Endoscopy and imaging (2023 / 2026)
  • Year 1: Endoscopy and imaging (2021 / 2024)
  • Year 2: Endoscopy and imaging (2022 / 2025)
Year 3: Endoscopy and imaging (2023 / 2026)

Quality in endoscopic practice
•    Understanding the importance of establishing quality measurements in endoscopy and its relationship with post endoscopic cancer (Upper and Lower GI endoscopy)
•    Overview of the different quality measurements in biliopancreatic endoscopy. How to set up a safe and efficient endoscopic service 
•    Training and quality in emergency care

Video Case Sessions

Biliary cannulation, spincterotomy/precut and stone disease and ERCP in altered anatomy
•    Biliary cannulation: Papillary and ductal anatomy, cannulation techniques, including device, guidewire/contrast use, double guidewire
•    EUS assisted biliopancreatic duct access 
•    Biliary disease: diagnosis, standard and advanced techniques 
•    ERCP in altered anatomy: identification of the desired loop and cannulation techniques in patients with altered anatomy

Endoscopic diagnosis and management of Barrett's oesophagus and associated neoplasia, early gastric and duodenal lesions
•    Barrett´s oesophagus and associated neoplasia: characterization of Barrett´s and visible lesions, resection techniques (EMR, ESD) and ablation techniques (RFA and Cryo)

Year 1: Endoscopy and imaging (2021 / 2024)

Advanced diagnostic endoscopy
•    Techniques for enhancing endoscopic vision: Chromo-endoscopy, high definition, NBI, FICE and endo-microscopy
•    Intraductal exploration with cholangioscopy
•    Enhancing EUS: Elastography, sonoview and endo-microscopy

Malignant biliary obstruction
•    Differential diagnosis of biliary strictures: Clinical assessment, laboratory tests, imaging techniques and tissue acquisition
•    The role of endoscopy and surgery in the management of malignant biliary strictures

Video Case Sessions

Endoscopic management of pancreatobiliary diseases
•    Endoscopic diagnosis and treatment of hilar and distal biliary strictures, including diagnosis with cholangioscopy and treatment with stenting
•    Endoscopic management of strictures and stones in patients with chronic pancreatitis
•    Endoscopic diagnosis of pancreatic cysts: EUS for the diagnosis of pancreatic cystic lesions, differential diagnosis, tools to enhance diagnosis

Endoscopic treatment of mid and lower gut diseases (excluding polyps)
•    Diagnostic and therapeutic management for lower GI bleeding, including timing and modalities for endoscopic treatment
•    Diagnosis and therapeutic management in small bowel disease, including indications and modalities for deep enteroscopy, as well as management for suspected small bowel bleeding and polyp resection
•    Endoscopic management of patients with IBD: colon cancer surveillance, polyp and stricture management
•    Endoscopic management of GI strictures (oesophageal, duodenal and colon: dilation and stent insertion)

Year 2: Endoscopy and imaging (2022 / 2025)

Advanced therapeutic endoscopic techniques
•    Difficult papilla and altered anatomy: Alternative approaches to ERCP
•    ERCP for difficult stones including cholangioscopy
•    Overview on EUS-guided therapeutic procedures

Video Case Sessions

Upper GI bleeding and endoscopic therapy of endoscopic and surgical complications
•    Overall and endoscopic management of patients with variceal bleeding
•    Overall and endoscopic management of patients with non-variceal bleeding
•    Haemostatic techniques in variceal and non-variceal bleeding
•    Endoscopic management of endoscopic complications (perforations) and surgical complications 

Endoscopic handling of colorectal polyps and treatment of pancreatic collections
•    Characterisation and resection techniques of colorectal polyps
•    EUS-guided drainage for pseudocysts and walled-off necrosis
•    Endoscopic necrosectomy techniques

  • Year 3: IBD (2023 / 2026)
  • Year 1: IBD (2021 / 2024)
  • Year 2: IBD (2022 / 2025)
Year 3: IBD (2023 / 2026)

How to use drugs in IBD
•    Modalities of therapeutic drug monitoring of biologics
•    Combinatorial use of biologics: Risks and benefits
•    Biomarker driven therapy, mucosal healing 
•    STRIDE and top up  
     Prevention and management of drug-related complications 

Management of ulcerative colitis (UC)
•    Standard therapeutic management of patients with UC
•    The optimal use of 5-ASA therapy
•    Therapy with thiopurines: Is there still a role in UC and for whom?
•    Anti-TNF and anti-integrins and JAK inhibitors: Mechanisms and optimal use in UC and the use of newer pharmacological agents
•    When should surgery be considered in UC?

Monitoring of disease activity in IBD
•    Objective measures of disease activity
•    Ultrasound, MRI capsule endoscopy and endoscopy 
•    Biochemical markers 

Year 1: IBD (2021 / 2024)

Difficult to treat IBD
•    How to define treatment failure and refractory IBD
•    Infectious complications to consider
•    Therapeutic options in patients failing biological agents
•    The role of surgery in refractory cases

Early management of IBD
•    Differential diagnosis of the patient with chronic diarrhoea
•    Diagnostic work-up and use of laboratory tests, imaging and endoscopy.
•    Therapeutic management in early stages

Extraintestinal manifestations of IBD
•    Epidemiology of extra-intestinal manifestations of IBD (PSC, skin, joints)
•    Clinical manifestations and diagnostic strategy
•    Therapeutic considerations with relation to IBD

Therapy update in IBD (in addition for 2020 only)
•    Non-complicated ileal Crohn's disease: biologics or watchful waiting?
•    New options in acute severe ulcerative colitis
•    Perianal Crohn's disease
•    Most promising mechanisms

Year 2: IBD (2022 / 2025)

Cancer and IBD
•    Pathophysiology of link between chronic inflammation and carcinogenesis
•    Surveillance schemes in patient with IBD according to risk factors
•    How to manage findings: Surgery and endoscopy

Management of Crohn's disease
•    Medical treatment algorithms
•    Objective measures for treatment and the role of complete mucosal healing
•    Interdisciplinary approach for perianal fistula

Management of ulcerative colitis: The acute patient
•    The hospitalised patient with acute colitis: Differential diagnosis
•    Medical management of ulcerative colitis
•    Surgery: Timing, types, outcome determining factors

  • Year 3: Liver (2023 / 2026)
  • Year 1: Liver (2021 / 2024)
  • Year 2: Liver (2022 / 2025)
Year 3: Liver (2023 / 2026)

Alcohol-related liver disease
•    Epidemiology of alcohol-related liver disease
•    Diagnosis and treatment of alcoholic hepatitis
•    Indications for liver transplantation
•    Management of alcohol dependence

Complications of cirrhosis and liver cancer
•    Ascites: Diagnostic and therapeutic approach
•    Diagnosis and treatment of hepatic encephalopathy
•    Nutrition and cirrhosis
•    Management of portal hypertension and its complications

Fulminant hepatitis, liver failure and liver transplantation
•    Diagnosis of fulminant liver failure, including differential diagnosis
•    Diagnostic work up for suspected drug induced liver injury (DILI)
•    Medical management
•    Transplantation and acute liver failure

Year 1: Liver (2021 / 2024)

Assessment of liver function
•    When to assess liver function
•    What methods are available for liver function assessment
•    How to predict and prevent liver failure prior to major surgery

Diagnostic work-up of a liver nodule
•    Differential diagnosis of liver nodules in the non-cirrhotic and cirrhotic liver
•    Diagnostic management: Imaging modalities and when to obtain tissue
•    Therapeutic management: Surveillance or treatment (except HCC)

•    Epidemiological concerns regarding NAFLD/NASH
•    How to differentiate from alcohol-related liver disease?
•    Relationship with the metabolic syndrome and cardiovascular diseases
•    Risk stratification
•    Therapeutic management

Viral hepatitis
•    The changing epidemiology of viral hepatitis
•    Diagnostic modalities for viral hepatitis
•    Therapeutic management
•    Long-term complications
•    HCV elimination: strategies, micro-elimination and possible target groups

Year 2: Liver (2022 / 2025)

Hepatocellular carcinoma (HCC)
•    Diagnostic modalities and differential diagnosis
•    Staging and classifications
•    Treatment algorithms and the role of liver transplantation

Liver and pregnancy
•    Overview of specific liver diseases in pregnancy, according to birth term.
•    Other liver diseases diagnosed during pregnancy
•    Management of liver diseases, including when to terminate pregnancy

Metabolic and vascular disorders of the liver
•    Overview of metabolic disorders: Diagnosis and therapy
•    The place of genetic evaluation in diagnostic work up
•    Vascular disorders of the liver: Diagnostic work up
•    Management of vascular disorders: The role of anticoagulation, TIPS and liver transplantation

  • Year 3: Oesophagus (2023 / 2026)
  • Year 1: Oesophagus (2021 / 2024)
  • Year 2: Oesophagus (2022 / 2025)
Year 3: Oesophagus (2023 / 2026)

Oesophageal cancer
•    Overview of diagnosis and staging
•    Management of early oesophageal cancer
•    Review the role of systemic therapy

Swallowing disorders: Oropharyngeal dysphagia
•    Causes of oropharyngeal dysphagia, including Zenker diverticulum and cricopharyngeal bar
•    Initial bedside and specialist investigation
•    Treatment of oropharyngeal dysphagia and other symptoms
•    Management of Zenker diverticulum including recurrence

Year 1: Oesophagus (2021 / 2024)

Benign causes of oesophageal dysphagia
•    Clinical presentation and differential diagnosis of dysphagia
•    Diagnostic modalities for determining diagnosis
•    Therapeutic management of benign oesophageal dysphagia (Eosinophilic oesophagitis, oe-sophageal motility disorders etc.)

Management of gastro-oesophageal reflux disease (GORD)
•    Concepts of GORD pathophysiology and diagnostic classification
•    Appropriate use of different modalities for GORD diagnosis (pH-metry, pH-impedance etc.)
•    Pharmacological therapy
•    Non-pharmacological therapy, including endoscopic procedures and surgery

Year 2: Oesophagus (2022 / 2025)

Barrett’s oesophagus
•    Epidemiology, aetiology and the risk of cancer
•    Diagnosis and classification
•    Surveillance schemes according to risk
•    Chemoprevention
•    Endoscopic management

Non-cardiac chest pain
•    Differential diagnosis of oesophageal chest pain
•    How to investigate, including the use of reflux studies and manometry
•    Pharmacological therapy: PPI and beyond

  • Year 3: Nutrition (2023 / 2026)
  • Year 1: Nutrition (2021 / 2024)
  • Year 2: Nutrition (2022 / 2025)
Year 3: Nutrition (2023 / 2026)

Anorexia and unexplained weight loss
•    Optimal diagnostic work-up for patients with unexplained weight loss because of reduced appetite and oral intake
•    Differentiating between organic causes and food-intake behavioural problems
•    Therapeutic multimodal management

Complications in nutrition and how to avoid them
•    Prevention and treatment of the refeeding syndrome
•    Complications of enteral access insertion (gastrostomy, jejunostomy, etc.) and enteral nutrition
•    Complications of home parenteral nutrition

Year 1: Nutrition (2021 / 2024)

Diagnosis and treatment of malnutrition
•    Definition and criteria of malnutrition
•    Tools for sarcopenia assessment
•    Identifying which patient is at risk
•    Artificial nutrition (enteral and parenteral): Indications and modalities of administration
•    Ethical considerations regarding artificial nutrition

Year 2: Nutrition (2022 / 2025)

•    Mechanisms of nutrient absorption and pathophysiology of malabsorption
•    Clinical features and differential diagnosis of the underlying diseases
•    Therapeutic management

Nutrition in GI diseases
•    Nutrition in IBD
•    Nutrition and NASH
•    Nutrition in patients with advanced liver disease, including pre- and post-transplantation, with a focus on sarcopenia / frailty
•    Nutrition in patients with gastrointestinal cancer, including perioperative nutrition

  • Year 3: Pancreas and biliary tract (2023 / 2026)
  • Year 1: Pancreas and biliary tract (2021 / 2024)
  • Year 2: Pancreas and biliary tract (2022 / 2025)
Year 3: Pancreas and biliary tract (2023 / 2026)

Autoimmune pancreatitis
•    Epidemiology, clinical presentation and subtypes of auto-immune pancreatitis
•    Diagnostic work-up and differential diagnosis with pancreatic cancer
•    Current treatment options
•    lgG4 related disease and associated disorders

Chronic pancreatitis
•    Pathophysiological mechanisms
•    Clinical aspects of chronic pancreatitis, including etiological factors, symptoms and complications
•    Therapeutic management strategy: Medical management, endoscopy and surgery

Pancreatic neuroendocrine tumours
•    Clinical spectrum of P-NETs
•    Diagnostic work-up
•    Curative, symptomatic and palliative therapeutic algorithm

Severe acute pancreatitis: Initial management and complications
•    Optimal management of severe acute necrotizing pancreatitis
•    Clinical and imaging aspects of pancreatic collections
•    Indications, timing, therapeutic modalities for drainage (surgical, endoscopic, radiological)

Year 1: Pancreas and biliary tract (2021 / 2024)

Management of acute pancreatitis
•    How to stage severity in acute pancreatitis
•    Determination of aetiology
•    Initial management: Hydration, antibiotics or not, nutrition, ERCP for biliary acute pancreatitis
•    Work-up for recurrent acute pancreatitis

Pancreatic adenocarcinoma
•    Diagnostic work-up and pitfalls of available diagnostic modalities
•    Therapeutic management: chemotherapy and surgery, including management of elderly pa-tients
•    Palliation: The role of endoscopy, nutrition and pain management

Year 2: Pancreas and biliary tract (2022 / 2025)

Autoimmune disease of liver and bile ducts
•    Differential diagnosis and therapy of autoimmune liver disease: AIH, PBC, PSC and other cholangiopathies
•    Typical symptoms, histology, sensitivity and specificity of serology of autoimmune liver disease
•    Alternative diagnosis to exclude
•    Natural course of the disease and possible therapeutic interventions

Biliary stones
•    Clinical symptoms and imaging modalities for diagnosis of bile stones
•    Managing symptomatic biliary stones, including gallstones and choledocolithiasis
•    Defining indication and timing of EUS, ERCP and cholecystectomy

•    Diagnosis, classification and staging of cholangiocarcinoma
•    Indications and modalities for surgical resection
•    Indications for pre-operative tissue acquisition and stenting
•    The role of endoscopy and radiology for palliation and their limitations

Cystic pancreatic lesions
•    Differential diagnosis of cystic pancreatic lesions and the role of CT, MRI and EUS
•    Natural history of pancreatic cystic lesions and risk of malignant transformation
•    Management of cystic pancreatic lesions and the indications for surgery

  • Year 3: Small bowel (2023 / 2026)
  • Year 1: Small bowel (2021 / 2024)
  • Year 2: Small bowel (2022 / 2025)
Year 3: Small bowel (2023 / 2026)

Obstruction and ileus
•    Differential diagnosis and investigation of ileusand obstruction
•    Management of ileus and obstruction
•    Management of chronic intestinal pseudo-obstruction and other similar disorders
•    Management of acute and chronic ischaemia 

Small bowel tumours
•    Clinical symptoms and diagnostic work-up
•    Overview of differential diagnosis, including neuroendocrine tumours
•    Therapeutic management

Year 1: Small bowel (2021 / 2024)

Chronic intestinal failure
•    Causes of chronic intestinal failure
•    Short and long-term complications of chronic intestinal failure
•    Management of chronic intestinal failure: Total parenteral nutrition and beyond (including transplantation)

Coeliac disease
•    Coeliac disease: Epidemiology, diagnosis and therapeutic management
•    How to differentiate between coeliac disease, eosinophilic gastroenteritis, food allergies, non-coeliac gluten sensitivity and IBS
•    Refractory coeliac disease

Year 2: Small bowel (2022 / 2025)

Small bowel imaging and endoscopy
•    Overview of available modalities for small bowel imaging: capsule endoscopy, radiology studies, MRI, deep enteroscopy techniques
•    Occult blood loss: How to investigate and how to treat
•    Small bowel polyp resection (Peutz Jeghers)

  • Year 3: Stomach (2023 / 2026)
  • Year 1: Stomach (2021 / 2024)
  • Year 2: Stomach (2022 / 2025)
Year 3: Stomach (2023 / 2026)

Gastric polyps and submucosal lesions
•    Clinical, endoscopic and histopathological features of gastric polyps and submucosal lesions
•    Possible syndromes that might be associated with gastric polyps
•    Therapeutic management
•    Autoimmune gastritis

Peptic ulcer disease
•    Epidemiology and incidence of peptic ulcer disease
•    Management of gastric ulcer
•    Complications of peptic ulcer disease

Year 1: Stomach (2021 / 2024)

Dyspepsia and gastroparesis
•    Definition and differential diagnosis of nausea and vomiting
•    Use of diagnostic tests such as imaging procedures and gastric emptying time
•    Pharmacological and non-pharmacological therapy for gastroparesis
•    Management of functional dyspepsia

H. pylori
•    Epidemiology and consequences of H. pylori infection
•    Available diagnostic modalities and their pitfalls
•    Effects on H. pylori infection on other organs and diseases
•    Eradication schemes and treatment resistance

Upper GI bleeding
•    Clinical assessment, investigation and therapy for acute upper GI bleeding, including special requirements for elderly patients
•    Management of patients on anticoagulant and anti-platelet therapy, both in the acute situation and before scheduled diagnostic or therapeutic endoscopy

Year 2: Stomach (2022 / 2025)

Bariatric surgery
•    Indications and techniques for bariatric surgery and their mechanisms of actions
•    Complications following bariatric surgery and their management
•    Long-term physiological consequences of bariatric surgery and its metabolic complications

Gastric cancer
•    Epidemiology, risk factors and screening requirements
•    Diagnostic modalities for early and advanced cancer, including chromoendoscopy, electronic chromoendoscopy and imaging procedures
•    Therapeutic management: endoscopy and surgery

  • Year 3: Therapy update (2023)
  • Year 1: Therapy update (2024)
  • Year 2: Therapy update (2022)
Year 3: Therapy update (2023)

•    Overview of the epidemiological data around diet and risk of IBD 
•    Understanding trial data regarding use of nutritional strategies as therapy for patients with CD and UC 
•    Be able to offer evidence-based dietary advice to patients across the spectrum of IBD 
•    Appreciate the role of the dietician in the IBD MDT

Year 1: Therapy update (2024)

The upcoming topic and learning objectives will be determined annually by the UEG Scientific Committee.

Year 2: Therapy update (2022)

Checkpoint inhibitors in GI-disease: Boon and bane 

  • Indications for check-point inhibitors in GI-Cancer
  • Diagnosis and differential diagnosis of Toxicity of Check-point inhibitor therapy
  • Treatment of GI-toxicity of CPI, criteria for treatment discontinuation of CPI due to side effects

Programme & Education Management
Elisabeth Pfeiffer
  • M: +43 699 1997 16 23
  • T: +43 1 997 16 39